Panasonic Healthcare to Buy Bayer Diabetes Devices Business
By HospiMedica International staff writers Posted on 08 Mar 2015 |
Bayer AG (Leverkusen, Germany) is slated to sell its diabetes devices business to Panasonic Healthcare (Osaka, Japan), continuing Bayer’s strategy of selling off peripheral businesses to focus on its core profitable ones.
Bayer has been trying to find a buyer for the faltering diabetes devices business since 2012 as a result of tight public healthcare budgets, increased competition, and reimbursement pressures, but failed to generate sufficient interest from potential suitors at the time. The main product of the Bayer diabetes devices business is the Contour blood glucose meter, which has seen declining sales since 2013, making it the worst performing product of the Bayer during the period.
Bayer also plans to list its Material Science Plastics Unit on the stock market; an initial public offering is reportedly targeted for mid-2016. In May 2014, the company bought the Merck (Darmstadt, Germany) over-the-counter (OTC) drug business for USD 14.2 billion, and the company has also expressed interest in acquisitions in veterinary medicine and crop protection products. The Bayer diabetes device unit is expected to generate between USD 1.1 and 2.3 billion.
“The plans will affect Bayer’s other entities including the HealthCare and CropScience units and its holding and service companies. The reorganization, due to be completed in January 2016, was announced Wednesday in a letter to employees,” said Guenter Forneck, a spokesman for Bayer, in a telephone interview with Bloomberg. “We will be a pure life-sciences company and must organize ourselves as such. No decisions had been made about how the remaining businesses will be affected.”
Entry into the diabetes business would be a new direction for Panasonic Healthcare, whose current focus is on the development, manufacture, and sale of biotechnology products (including cryogenic freezers, refrigerators, incubators, and environmental chambers), in vitro diagnostic devices and services, and medical information technology (IT) solutions.
Related Links:
Bayer AG
Panasonic Healthcare
Merck
Bayer has been trying to find a buyer for the faltering diabetes devices business since 2012 as a result of tight public healthcare budgets, increased competition, and reimbursement pressures, but failed to generate sufficient interest from potential suitors at the time. The main product of the Bayer diabetes devices business is the Contour blood glucose meter, which has seen declining sales since 2013, making it the worst performing product of the Bayer during the period.
Bayer also plans to list its Material Science Plastics Unit on the stock market; an initial public offering is reportedly targeted for mid-2016. In May 2014, the company bought the Merck (Darmstadt, Germany) over-the-counter (OTC) drug business for USD 14.2 billion, and the company has also expressed interest in acquisitions in veterinary medicine and crop protection products. The Bayer diabetes device unit is expected to generate between USD 1.1 and 2.3 billion.
“The plans will affect Bayer’s other entities including the HealthCare and CropScience units and its holding and service companies. The reorganization, due to be completed in January 2016, was announced Wednesday in a letter to employees,” said Guenter Forneck, a spokesman for Bayer, in a telephone interview with Bloomberg. “We will be a pure life-sciences company and must organize ourselves as such. No decisions had been made about how the remaining businesses will be affected.”
Entry into the diabetes business would be a new direction for Panasonic Healthcare, whose current focus is on the development, manufacture, and sale of biotechnology products (including cryogenic freezers, refrigerators, incubators, and environmental chambers), in vitro diagnostic devices and services, and medical information technology (IT) solutions.
Related Links:
Bayer AG
Panasonic Healthcare
Merck
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures